A. Paul et al., P2Y receptor-mediated inhibition of tumor necrosis factor alpha-stimulatedstress-activated protein kinase activity in EAhy926 endothelial cells, J BIOL CHEM, 275(18), 2000, pp. 13243-13249
In the EAhy926 endothelial cell line, UTP, ATP, and forskolin, but not UDP
and epidermal growth factor, inhibited tumor necrosis factor alpha (TNF alp
ha)- and sorbitol stimulation of the stress-activated protein kinases, JNK,
and p38 mitogen-activated protein (MAP) kinase, and MAPKAP kinase-2, the d
ownstream target of p38 MAP kinase. In NCT2544 keratinocytes, UTP and a pro
teinase-activated receptor-a agonist caused similar inhibition, but in 1312
1N1 cells, transfected with the human P2Y(2) or P2Y(4) receptor, UTP stimul
ated JNK and p38 MAP kinase activities. This suggests that the effects medi
ated by P2Y receptors are cell-specific. The inhibitory effects of UTP were
not due to induction of MAP kinase phosphatase-1, but were manifest upstre
am in the pathway at the level, of MEK-4. The inhibitory effect of UTP was
insensitive to the MEK-1 inhibitor PD 098059, changes in intracellular Ca2 levels, or pertussis toxin, Acute phorbol 12-myristate 13-acetate pretreat
ment also inhibited TNF alpha-stimulated SAP kinase activity, while chronic
pretreatment reversed the effects of UTP. Furthermore, the protein kinase
C inhibitors Ro318220 and Go6983 reversed the inhibitory action of UTP, but
GF109203X was ineffective. These results indicate a novel mechanism of cro
ss-talk regulation between P2Y receptors and TNF alpha-stimulated SAP kinas
e pathways in endothelial cells, mediated by Ca2+-independent isoforms of p
rotein kinase C.